News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News News 28/03/2021 Of 72 antivirals tested in the laboratory, plitidepsin proves to be the most effective in preventing SARS-CoV-2 replication 09/03/2021 Therapeutic HIV vaccine achieves an immune response that improves viral control when antiretroviral treatment is interrupted 07/03/2021 Both antibodies generated by vaccination and by natural infection block the SARS-CoV-2 variant described in England 25/02/2021 Condolences for the loss of Charles Boucher 14/02/2021 Recommendations on vaccination of people with evidence of previous SARS-CoV-2 infection 07/02/2021 Blocking the spread of HIV or favouring the spread of the tuberculosis bacteria, the flip side of the Siglec-1 protein's absence 22/12/2020 Announcement on the new SARS-CoV-2 strain, variant VUI-202012/01 21/12/2020 Pre-clinical studies confirm that the CPC component of some mouthwashes reduces the infectivity of SARS-CoV-2 16/12/2020 Protective antibodies against COVID-19 are maintained for a minimum of six months Pagination First Previous … Page 4 Page 5 Page 6 Page 7 8 Page 9 Page 10 Page 11 Page 12 … Next Last
28/03/2021 Of 72 antivirals tested in the laboratory, plitidepsin proves to be the most effective in preventing SARS-CoV-2 replication
09/03/2021 Therapeutic HIV vaccine achieves an immune response that improves viral control when antiretroviral treatment is interrupted
07/03/2021 Both antibodies generated by vaccination and by natural infection block the SARS-CoV-2 variant described in England
07/02/2021 Blocking the spread of HIV or favouring the spread of the tuberculosis bacteria, the flip side of the Siglec-1 protein's absence
21/12/2020 Pre-clinical studies confirm that the CPC component of some mouthwashes reduces the infectivity of SARS-CoV-2
